Ing Groep Nv Elanco Animal Health Inc Transaction History

Ing Groep Nv

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$14.37 - $16.46 $79,035 - $90,530	5,500 Added 7.71%	76,800 $1.25 Million
Q4 2023 Feb 08, 2024	BUY	$8.6 - $14.94 $613,180 - $1.07 Million	71,300 New	71,300 $1.06 Million
Q4 2022 Feb 10, 2023	BUY	$11.49 - $13.65 $6.89 Million - $8.19 Million	600,000 New	600,000 $7.33 Million
Q3 2021 Nov 02, 2021	SELL	$29.2 - $36.72 $8.03 Million - $10.1 Million	-275,000 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$28.76 - $35.98 $7.91 Million - $9.89 Million	275,000 New	275,000 $9.54 Million
Q3 2020 Nov 12, 2020	SELL	$21.1 - $29.13 $9.12 Million - $12.6 Million	-432,199 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$18.94 - $24.93 $8.19 Million - $10.8 Million	432,199 New	432,199 $9.27 Million

438

473M

4.62M

753K

Ticker ELAN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 474,113,984
Market Cap $6.63B
Description
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...

Get notified when there are updates to the investment portfolio of Ing Groep Nv, based on Form 13F filings with the SEC.

Stay updated on Ing Groep Nv with notifications on news.